FDA Denies Authorization to Market JUUL Products

The U.S. Food and Drug Administration issued marketing denial orders to JUUL Labs Inc. for all of their products currently marketed in the United States.

Previous
Previous

First mosquito-borne virus of 2022 detected in Michigan mosquitoes

Next
Next

FDA Announces Plans for Proposed Rule to Reduce Addictiveness of Cigarettes and Other Combusted Tobacco Products